Private Equity

A regulatory filing reveals a key investor's move as Alkermes' $2.1B bid for Avadel and its blockbuster narcolepsy drug, LUMRYZ, nears its final act.

The Army is outsourcing pilot training. A new alliance of industry and academia aims to win the bid, blending operational scale with proven teaching excellence.

A $2.4B deal for AI's future. A hedge fund's strategic play. We decode the battle for Alphawave, the company powering the next tech revolution.

A $2.4B semiconductor deal seems distant from medicine, but it's forging the AI hardware backbone for the next generation of precision health.

Bregal Milestone's majority investment in Beyond Now is more than a deal; it’s a bet on how Agentic AI will rewire complex digital supply chains.

With a new $2B share buyback and strong dividends, Royal Caribbean isn't just recovering; it's setting a new course for shareholder value and growth.

Chatham Lodging Trust's dividend hike isn't just a payout. It’s a strategic signal about the future of upscale travel and savvy hotel investment.

Balyasny Asset Management's complex derivative stake in JTC plc reveals the hidden strategies shaping a major takeover and the capital flows funding innovation.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

Beyond sugar and spice, America's historic hotels are using elaborate gingerbread displays as a calculated investment in brand equity and holiday revenue.

A crypto fund's nomination for a top award signals a new era for family offices seeking managed risk and high returns in the volatile digital asset market.

Copper Quest diversifies from copper, acquiring a high-grade gold mine and adding 150+ years of mining expertise to its board and advisory team.

Beyond philanthropy, KinderCare's alumni scholarship is a strategic investment in its brand, building a human capital pipeline from the ground up.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

A routine filing reveals Marathon Asset Management's 3.68% stake in John Wood Group. What does this calculated play signal for the firm's takeover?

UNFI unveils an ambitious strategy to hit $800M in EBITDA by 2028, shifting focus from pure sales to deep operational and digital transformation.

Applegate unites with 11 mission-driven brands in a campaign that redefines partnerships, weaving CSR and consumer engagement into a powerful new strategy.

Beyond a simple payout, Amerigo Resources’ latest dividend reveals a powerful strategy of innovation, financial discipline, and a bullish copper market.

Providence Care's new CEO is a former therapist. Can his clinical insight solve market challenges and deliver on a private equity growth plan?

Capital Power unveils a $3B deal with Apollo to buy U.S. gas plants while securing a major deal to power Alberta's AI boom, a bold dual strategy.